Eli Lilly & Co. (LLY) Tops Q1 EPS by 9c; Reaffirms FY13 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street falls as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Analyst Encouraged by Eli Lilly (LLY) Cost Containment Efforts
April 24, 2013 1:15 PM EDTThis morning Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.66 billion. Shares traded lower by nearly 3 percent in response.
Commenting on news,... More
